Form 4: Precigen Director Jeffrey Kindler Reports Acquisition and Disposal of Common Stock and Restricted Stock Units

Director Jeffrey Kindler reports transactions involving Precigen, Inc. common stock and restricted stock units, including acquisitions and disposals.

Summary

• On March 13, 2025, Jeffrey Kindler acquired 39,655 shares of Precigen common stock at $1.74 per share and disposed of an unspecified amount, resulting in beneficial ownership of 433,018 shares.
• On the same day, Kindler acquired 71,839 restricted stock units (RSUs) that vest in full on March 13, 2026, and also acquired an option to purchase 83,517 shares of common stock at $1.74, exercisable from March 13, 2025, to March 13, 2035.
• On March 14, 2025, Kindler disposed of an unspecified amount of common stock and vested 87,412 RSUs, resulting in beneficial ownership of 520,430 shares.
• The shares acquired on March 13, 2025, were issued in lieu of an annual retainer of $69,000.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine filing of insider transactions. The acquisition of shares in lieu of a retainer and vesting of RSUs can be seen as a positive sign of alignment with company interests, but it's not significantly impactful.

Positives

• The acquisition of shares in lieu of a retainer demonstrates Kindler's continued investment in the company.
• The vesting of RSUs and acquisition of stock options incentivize Kindler to contribute to the company's long-term success.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• Shareholders can monitor insider transactions to gain insights into management's perspective on the company's value and future prospects.

Key Dates